129 related articles for article (PubMed ID: 38703039)
1. Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small-cell lung cancer.
Mikkelsen AW; Nilsson AC; Tenstad HB; Lillevang ST; Asgari N
Thorac Cancer; 2024 Jun; 15(17):1350-1356. PubMed ID: 38703039
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic autoimmunity and small-cell lung cancer: Neurological and serological accompaniments.
Zekeridou A; Majed M; Heliopoulos I; Lennon VA
Thorac Cancer; 2019 Apr; 10(4):1001-1004. PubMed ID: 30810271
[TBL] [Abstract][Full Text] [Related]
3. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy.
Galanis E; Frytak S; Rowland KM; Sloan JA; Lennon VA
Cancer Immunol Immunother; 1999; 48(2-3):85-90. PubMed ID: 10414461
[TBL] [Abstract][Full Text] [Related]
4. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
5. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
6. Immune response in lung cancer mouse model mimics human anti-Hu reactivity.
Kazarian M; Calbo J; Proost N; Carpenter CL; Berns A; Laird-Offringa IA
J Neuroimmunol; 2009 Dec; 217(1-2):38-45. PubMed ID: 19765830
[TBL] [Abstract][Full Text] [Related]
7. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
8. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
9. Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
Gozzard P; Chapman C; Vincent A; Lang B; Maddison P
PLoS One; 2015; 10(11):e0143558. PubMed ID: 26606748
[TBL] [Abstract][Full Text] [Related]
10. Low level anti-Hu reactivity: A risk marker for small cell lung cancer?
Tsou JA; Kazarian M; Patel A; Galler JS; Laird-Offringa IA; Carpenter CL; London SJ
Cancer Detect Prev; 2009; 32(4):292-9. PubMed ID: 19070439
[TBL] [Abstract][Full Text] [Related]
11. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
Kazarian M; Laird-Offringa IA
Mol Cancer; 2011 Mar; 10():33. PubMed ID: 21450098
[TBL] [Abstract][Full Text] [Related]
12. Complicated paraneoplastic neurological syndromes: a report of two patients with small cell or non-small cell lung cancer.
Hiasa Y; Kunishige M; Mitsui T; Kondo S; Kuriwaka R; Shigekiyo S; Kanematsu T; Satake N; Bando Y; Kondo A; Endo I; Oshima Y; Matsumoto T
Clin Neurol Neurosurg; 2003 Dec; 106(1):47-9. PubMed ID: 14643918
[TBL] [Abstract][Full Text] [Related]
13. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
14. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
[TBL] [Abstract][Full Text] [Related]
15. Anti-Hu Positive Antibodies and Small Cell Carcinoma: A Single Center Review.
List M; Jamous F; Gupta A; Huntington M
S D Med; 2015 Jun; 68(6):251, 253-5. PubMed ID: 26137725
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.
Maddison P; Thorpe A; Silcocks P; Robertson JF; Chapman CJ
Lung Cancer; 2010 Dec; 70(3):335-9. PubMed ID: 20371131
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
Maddison P; Lang B
J Neuroimmunol; 2008 Sep; 201-202():159-62. PubMed ID: 18667241
[TBL] [Abstract][Full Text] [Related]
18. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders.
Maddison P; Titulaer MJ; Verschuuren JJ; Gozzard P; Lang B; Irani SR; Sabater L; Graus F; Murray A; Chapman CJ
J Neuroimmunol; 2019 Jan; 326():14-18. PubMed ID: 30445363
[TBL] [Abstract][Full Text] [Related]
19. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
[TBL] [Abstract][Full Text] [Related]
20. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.
Höftberger R; Titulaer MJ; Sabater L; Dome B; Rózsás A; Hegedus B; Hoda MA; Laszlo V; Ankersmit HJ; Harms L; Boyero S; de Felipe A; Saiz A; Dalmau J; Graus F
Neurology; 2013 Oct; 81(17):1500-6. PubMed ID: 24068784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]